DASH Diet for Diabetes With Low Sodium Reduces BP in Those With Diabetes
By Lori Solomon HealthDay Reporter
WEDNESDAY, June 18, 2025 -- The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in people with diabetes, according to a study published online June 9 in JAMA Internal Medicine.
Scott J. Pilla, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues examined the effects of a DASH-style diet and sodium reduction on blood pressure in adults with type 2 diabetes. The analysis included 102 adults with type 2 diabetes, a systolic blood pressure of 120 to 159 mm Hg, and a diastolic blood pressure of <100 mm Hg, who were randomly assigned to a sequence of four diets, each for five weeks: (1) DASH4D diet with lower sodium, (2) DASH4D diet with higher sodium, (3) comparison (typical U.S.) diet with lower sodium, and (4) comparison diet with higher sodium (reference).
The researchers found that compared with the comparison diet with higher sodium, the DASH4D diet with lower sodium reduced end-of-period systolic blood pressure by 4.6 mm Hg and diastolic blood pressure by 2.3 mm Hg. The first three weeks of each diet were when most blood pressure reduction occurred. The effect of sodium reduction appeared stronger than the effect of the DASH4D diet. For each diet, adverse events were infrequent.
"Most people in this study were taking more than one blood pressure medication, but we found that you can lower it further with dietary change," coauthor Lawrence Appel, M.D., also from Johns Hopkins University, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension
MONDAY, July 21, 2025 -- For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved...
CDC, FDA Warn of Possible Salmonella Risk From Frozen Sprouted Beans
FRIDAY, July 18, 2025 -- The U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration, along with public health officials in several states, are...
ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension
FRIDAY, July 18, 2025 -- All individuals with hypertension should be screened for primary aldosteronism (PA), according to a clinical practice guideline issued by the Endocrine...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.